These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11464989

  • 1. Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy.
    McNall RY, Head DR, Pui CH, Razzouk BI.
    J Pediatr Hematol Oncol; 2001; 23(5):309-11. PubMed ID: 11464989
    [Abstract] [Full Text] [Related]

  • 2. Aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia.
    Azzi A, Macchia PA, Favre C, Nardi M, Zakrzewska K, Corsi OB.
    Haematologica; 1989; 74(2):191-4. PubMed ID: 2545576
    [Abstract] [Full Text] [Related]

  • 3. Parvovirus B19 infection presenting as pre-B-cell acute lymphoblastic leukemia: a transient and progressive course in two children.
    Yetgin S, Cetin M, Aslan D, Ozyurek E, Anlar B, Uçkan D.
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):689-92. PubMed ID: 15454845
    [Abstract] [Full Text] [Related]

  • 4. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
    Isobe Y, Sugimoto K, Shiraki Y, Nishitani M, Koike K, Oshimi K.
    Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
    [Abstract] [Full Text] [Related]

  • 5. Parvovirus infection in a child with acute lymphoblastic leukemia.
    Alberti M, Fiori GM, Sanna MA.
    Haematologica; 1999 Jan; 84(1):85. PubMed ID: 10091396
    [No Abstract] [Full Text] [Related]

  • 6. bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
    Abla O, Gassas A, Stevens R, Grant R, Abdelhaleem M.
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):98-9. PubMed ID: 16462583
    [Abstract] [Full Text] [Related]

  • 7. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
    Hartmann JT, Meisinger I, Kröber SM, Weisel K, Klingel K, Kanz L.
    Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
    [Abstract] [Full Text] [Related]

  • 8. [Congenital aplastic anemia caused by parvovirus B19 infection].
    Vepreková L, Jelínek J, Zeman J.
    Cas Lek Cesk; 2001 Mar 29; 140(6):178-80. PubMed ID: 11347208
    [Abstract] [Full Text] [Related]

  • 9. Persistent and Prolonged Parvovirus B19 Viremia in a Pediatric Patient With Acute Lymphoblastic Leukemia.
    Fritch Lilla SA, Burgett SE, McGann KA, Wechsler DS.
    J Pediatric Infect Dis Soc; 2015 Sep 29; 4(3):e38-40. PubMed ID: 26407441
    [Abstract] [Full Text] [Related]

  • 10. The use of monoclonal antibody R92F6 and polymerase chain reaction to confirm the presence of parvovirus B19 in bone marrow specimens of patients with acquired immunodeficiency syndrome.
    Vadlamudi G, Rezuke WN, Ross JW, Cartun RW, Ackroyd R, Knibbs DR, Tsongalis GJ.
    Arch Pathol Lab Med; 1999 Sep 29; 123(9):768-73. PubMed ID: 10458821
    [Abstract] [Full Text] [Related]

  • 11. Parvovirus B19 presenting with persistent pancytopenia in a patient of T-ALL post induction chemotherapy diagnosed on bone marrow examination.
    Gadage VS, Viswanathan S, Kunal S, Subramanian PG, Gujral S.
    Indian J Pathol Microbiol; 2011 Sep 29; 54(3):603-5. PubMed ID: 21934234
    [Abstract] [Full Text] [Related]

  • 12. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease.
    Osaki M, Matsubara K, Iwasaki T, Kurata T, Nigami H, Harigaya H, Baba K.
    Ann Hematol; 1999 Feb 29; 78(2):83-6. PubMed ID: 10089023
    [Abstract] [Full Text] [Related]

  • 13. Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
    Hunault-Berger M, Milpied N, Bernard M, Jouet JP, Delain M, Desablens B, Sadoun A, Guilhot F, Casassus P, Ifrah N.
    Leukemia; 2001 Jun 29; 15(6):898-902. PubMed ID: 11417474
    [Abstract] [Full Text] [Related]

  • 14. Parvovirus B19.
    Landry ML.
    Microbiol Spectr; 2016 Jun 29; 4(3):. PubMed ID: 27337440
    [Abstract] [Full Text] [Related]

  • 15. Induction Failure in Acute Leukemia or Parvovirus B19 Infection?
    Tüfekçi Ö, Yilmaz Bengoa Ş, Erdem M, Ören H.
    J Pediatr Hematol Oncol; 2017 Oct 29; 39(7):565. PubMed ID: 28665873
    [Abstract] [Full Text] [Related]

  • 16. [Parvovirus B19-induced pure red cell aplasia in a liver transplant recipient].
    Lee EY, Cho Y, Lee SG, Song J.
    Korean J Lab Med; 2010 Dec 29; 30(6):591-4. PubMed ID: 21157144
    [Abstract] [Full Text] [Related]

  • 17. PARVOVIRUS B19 INFECTION PRESENTING AS ACUTE HEPATITIS AND TRANSIENT ANEMIA IN A PREVIOUSLY HEALTHY CHILD.
    Tesapirat L, Wanlapakorn N, Chieochansin T, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2015 Mar 29; 46(2):226-30. PubMed ID: 26513925
    [Abstract] [Full Text] [Related]

  • 18. Study on clinical characteristics and follow-up visit of acquired aplastic anemia associated with parvovirus B19 infection.
    Wen JQ, Zhou N, Li D, Feng HL, Wang H.
    Indian J Pediatr; 2012 Jun 29; 79(6):741-6. PubMed ID: 21830025
    [Abstract] [Full Text] [Related]

  • 19. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
    Lindblom A, Heyman M, Gustafsson I, Norbeck O, Kaldensjö T, Vernby A, Henter JI, Tolfvenstam T, Broliden K.
    Clin Infect Dis; 2008 Feb 15; 46(4):528-36. PubMed ID: 18194100
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemia.
    Petrella T, Bailly F, Mugneret F, Caillot D, Chavanet P, Guy H, Solary E, Waldner A, Devilliers E, Carli PM.
    Leuk Lymphoma; 1992 Nov 15; 8(4-5):415-9. PubMed ID: 1290967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.